Update on Full Year Results
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your KMK notes
Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, gives notice that, further to the Group's trading update of 29 May 2024 (the "Trading Update") in which it stated it expected to release its full year results in September 2024, the Group now expects to announce its final results for the year ended 30 April 2024 during the second half of October.
The Group is experiencing increasing commercial and strategic momentum and continues to pursue further initiatives across the business. As noted in the Trading Update, Kromek expects to report positive EBITDA for FY 2024, ahead of market expectations. This reflects an anticipated improvement in gross margin due to the product mix sold combined with the Group exerting continued tight cost control whilst driving operational efficiencies, particularly within its advanced imaging manufacturing process.
Further details will be provided in the Group's final results announcement.
Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.
Further information is available at www.kromek.com.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.